Clinical AI company Sensyne Health has signed a five-year strategic research agreement with Somerset NHS Foundation Trust.
The dataset covers just over one million unique patient records, with all data anonymised by Somerset beforehand.
This brings AIM-listed Sensyne’s total anonymised patient data available for analysis to 5.6 million patients.read more...
An Oxford firm that could hold the key to treating Alzheimer’s disease is one of four winning $1 million in the Microsoft-led Female Founders investment contest
Sufferers of severe back pain are closer to receiving a new type of less invasive, ultrasound-based treatment, as OrthoSon receives extra funding.
Drug discovery could be about to benefit from a new realm of AI being applied to the drug development process. Oxford-based Exscientia is making major inroads.
The Oxford University-led coronavirus vaccine trial passed two important hurdles this week: whether the vaccine will be safe to use and whether it induces good immune results.
Social distancing has accelerated the use of remote communications across healthcare, and myo's mobile app addresses isolation by helping caregivers to connect with their residents’ families.
Oxford’s digital transformation catalyst for health, TheHill, prides itself on supporting healthcare providers in getting innovative products to where they can help the most. TechTribe Oxford looks at some of those finding ways to meet the demands of Covid-19.
The Oxford Vaccine Group, working with the Jenner Institute on the Covid-19 trials, is using laundry services by Oxwash, the eco-friendly start-up.
Starting on 23 April, over a thousand volunteers will receive a Covid-19 candidate vaccine in trials led by Prof Sarah Gilbert at Oxford's Jenner Institute.
Healthcare workers are not in it for the money, nor because it is safest. Nye Health's comms solutions enable care to continue remotely through the crisis.
Imagine your body with its exact organ systems, cells and DNA, existing in 1’s and 0’s, on a silicon chip. This is what you would call a virtual twin, and research in Oxford indicates how far away we are from creating such a digital entity.
An Oxford startup has developed measurement technology for the efficiency of drug loading in nanoparticles and for monitoring nitrates and phosphates in water.
Fertility treatment technology firm VivoPlex has raised £3.9 million to develop its intra-uterine biosensor.
Matthew Cobb’s book charts the history of efforts to understand the brain and brings us up to date with the latest developments in neuroscience.
The OxVent ventilator for Covid-19 patients, developed in just two weeks in March by engineers and medics in Oxford and London, is being tested for safety and usability at the Smith+Nephew medical manufacturing facility in Hull.
Oxford biotech company e-therapeutics is offering its powerful network-biology-and AI-based drug discovery platform to help tackle the Covid-19 pandemic.
21st century technologies for tackling 21st century pandemics Prof Christophe Fraser of Oxford’s Big Data Institute, who advises the UK’s NHS Covid-19 Tracing app, and Prof Oliver Pybus, Lead Researcher of the Oxford Martin School Programme on Pandemic Genomics, discuss the opportunities and challenges of applying new technologies to pandemics. 5pm. Details
The EV Summit This two-day event brings together key players in electric vehicles, energy, information technology and charging infrastructure, to shape the debate and the contours of the new eMobility industry. Six hundred of the most connected people in the EV space will be invited to attend. Partners include EDFE, BCLP Law, Scottish and Southern Electricity Networks. Speakers so far include Fiona Howarth, CEO of Octopus EV and Guenter Butschek, CEO of Tata Motors. December 15 and 16, Saïd Business School, Oxford OX 1 1HP. Click here for details